review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1047179991 |
P356 | DOI | 10.1007/S00393-005-0733-5 |
P698 | PubMed publication ID | 15909083 |
P2093 | author name string | M Schneider | |
R Fischer-Betz | |||
S Beer | |||
P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
Factors associated with coronary artery calcification in young female patients with SLE. | Q33188178 | ||
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus | Q33329033 | ||
Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort | Q33915430 | ||
Systemic lupus erythematosus: a model for atherogenesis? | Q33922220 | ||
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
Atherosclerosis and autoimmunity | Q34243799 | ||
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus | Q35552185 | ||
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study | Q35552242 | ||
Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis | Q36747001 | ||
Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 | ||
Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population | Q42037849 | ||
Vascular stiffness in women with systemic lupus erythematosus | Q43576508 | ||
The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
Brachial endothelial function is impaired in patients with systemic lupus erythematosus | Q43884850 | ||
Mortality in systemic lupus erythematosus: the bimodal pattern revisited | Q43971969 | ||
Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities. | Q44300648 | ||
Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices | Q44589658 | ||
The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients | Q44593960 | ||
Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study | Q44652580 | ||
Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation | Q44810026 | ||
Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus | Q45081882 | ||
Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy | Q47389819 | ||
Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland | Q48660184 | ||
Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. | Q50658322 | ||
Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. | Q51578946 | ||
Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus | Q60680877 | ||
Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 | ||
Cardiovascular disease in systemic lupus erythematosus. A study of 75 patients form a defined population | Q68035493 | ||
Morbidity in systemic lupus erythematosus | Q69148719 | ||
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death | Q70245059 | ||
Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years | Q70715027 | ||
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus | Q73167867 | ||
Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study | Q77099358 | ||
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 | ||
Chronic infection and coronary artery disease | Q79299394 | ||
P433 | issue | 4 | |
P1104 | number of pages | 10 | |
P304 | page(s) | 229-238 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Zeitschrift fuer Rheumatologie | Q15763293 |
P1476 | title | [Accelerated atherosclerosis in rheumatic systemic diseases as an example of systemic lupus erythematosus--what is the consequence?] | |
P478 | volume | 64 |